• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS POWERLOC MAX POWER-INJECTIBLE INFUSION SET 22G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS POWERLOC MAX POWER-INJECTIBLE INFUSION SET 22G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 12/10/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of asdrf015 showed no other similar product complaint(s) from this lot number.
 
Event or Problem Description
It was reported that the tubing cracked at the hub causing leakage.No other information provided.
 
Event or Problem Description
It was reported that the tubing cracked at the hub causing leakage.No other information provided.(b)(6) 2020 - per air received: patient had port tubing break again - 24 hours after being admitted.This time chemo was infusing.Parents noticed a drop of methotrexate chemo and notified nurse.Nurse stopped chemo.According to nurses, tubing broke above needleless connector.Complainant believes this is the same place it has broken multiple times in the past.Patient had to be de-accessed, re-accessed, blood cultures were draw.Reminder of the chemo tubing was sent back to pharmacy, placed in a new bag and restarted later that day.This may be the 5th time this has happened.Complainant doesn't think there's been any change.The day before, when the patient was admitted, the rn notified the bedside rn about her experiences with the patient's port.Unfortunately, it was a very busy day.Complainant is not sure how the port was taped or if it was taped any differently.Complainant was not providing direct care to the patient.The next day, the complainant reported she happened to walk by right when the patient's port needle had broken so she told the nurse for that day that his has happened before.Complainant states there has not been any change and this happens to the patient every time she is admitted.Complainant states she doesn't think there is anything wrong with the port needle itself; she thinks the patient is so active, the tubing gets pulled/twisted on too much in the same place every time and it just breaks.Complainant suggests some form of communication be given to the nurses to dress and secure the port needle a different way or this will continue to occur.When filing this report, the complainant realized the patient had to be re-accessed twice: once the day after the needle came out and leaked according to the parents, and again two days later when it broke (fda report 3006260740-2020-00293).Tubing ruptured where it inserts into the hard plastic cap.The device leaked and was open to air, putting the patient at risk for bleeding.
 
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of asdrf015 showed no other similar product complaint(s) from this lot number.
 
Additional Manufacturer Narrative
H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of asdrf015 showed no other similar product complaint(s) from this lot number.
 
Event or Problem Description
It was reported that the tubing cracked at the hub causing leakage.No other information provided.(b)(6) 2020 - per air received: patient had port tubing break again - 24 hours after being admitted.This time chemo was infusing.Parents noticed a drop of methotrexate chemo and notified nurse.Nurse stopped chemo.According to nurses, tubing broke above needleless connector.Complainant believes this is the same place it has broken multiple times in the past.Patient had to be de-accessed, re-accessed, blood cultures were draw.Reminder of the chemo tubing was sent back to pharmacy, placed in a new bag and restarted later that day.This may be the 5th time this has happened.Complainant doesn't think there's been any change.The day before, when the patient was admitted, the rn notified the bedside rn about her experiences with the patient's port.Unfortunately, it was a very busy day.Complainant is not sure how the port was taped or if it was taped any differently.Complainant was not providing direct care to the patient.The next day, the complainant reported she happened to walk by right when the patient's port needle had broken so she told the nurse for that day that his has happened before.Complainant states there has not been any change and this happens to the patient every time she is admitted.Complainant states she doesn't think there is anything wrong with the port needle itself; she thinks the patient is so active, the tubing gets pulled/twisted on too much in the same place every time and it just breaks.Complainant suggests some form of communication be given to the nurses to dress and secure the port needle a different way or this will continue to occur.When filing this report, the complainant realized the patient had to be re-accessed twice: once the day after the needle came out and leaked according to the parents, and again two days later when it broke (fda report 3006260740-2020-00293).Tubing ruptured where it inserts into the hard plastic cap.The device leaked and was open to air, putting the patient at risk for bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 22G X 0.75IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
MDR Report Key9627582
Report Number3006260740-2020-00291
Device Sequence Number18936946
Product Code FPA
UDI-Device Identifier00801741047497
UDI-Public(01)00801741047497
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0142275
Device Lot NumberASDRF015
Was Device Available for Evaluation? No
Event Location Hospital
Initial Date Received by Manufacturer 01/03/2020
Supplement Date Received by Manufacturer05/01/2020
05/20/2020
Initial Report FDA Received Date01/24/2020
Supplement Report FDA Received Date05/19/2020
06/17/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
2243072-06/03/2020-006-R
Patient Sequence Number1
-
-